Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development-Reference-Cited by-同舟云学术

Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development

Published:2021-10-27 Issue:22 Volume:95 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Ballmann Mónika Z.¹,Raus Svjetlana²,Engelhart Ruben¹²,Kaján Győző L.³,Beqqali Abdelaziz²,Hadoke Patrick W. F.²,van der Zalm Chantal¹,Papp Tibor⁴,John Lijo³,Khan Selina⁴,Boedhoe Satish⁴,Danskog Katarina³,Frängsmyr Lars³,Custers Jerome⁴,Bakker Wilfried A. M.¹^ORCID,van der Schaar Hilde M.¹,Arnberg Niklas³,Lemckert Angelique A. C.¹,Havenga Menzo¹,Baker Andrew H.²^ORCID

Affiliation:

1. Batavia Biosciences B.V., Leiden, The Netherlands

2. Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, United Kingdom

3. Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå, Sweden

4. Janssen Vaccines and Prevention B.V., Leiden, The Netherlands

Abstract

Adenoviral vectors are under investigation for a broad range of therapeutic indications in diverse fields, such as oncology and gene therapy, as well as for vaccination both for human and veterinary use. A wealth of data shows that preexisting immune responses may limit the use of a vector.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.00387-21

Reference46 articles.

1. Immune Responses to Viral Gene Therapy Vectors

2. Adenoviral Vector-Based Vaccines and Gene Therapies: Current Status and Future Prospects

3. Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism

4. Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy

5. Author Correction: Genomic analysis of a large set of currently—and historically—important human adenovirus pathogens

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets;International Journal of Molecular Sciences;2024-07-04

2. Non‐coding RNAs to treat vascular smooth muscle cell dysfunction;British Journal of Pharmacology;2024-05-21

3. Construction of a bivalent vaccine candidate against HAdV4/HAdV7 based on capsid-display strategy via Red-homologous recombination and counter-selection methodology;Biosafety and Health;2024-04

4. Next-generation biological vector platforms for in vivo delivery of genome editing agents;Current Opinion in Biotechnology;2024-02

5. Building a Scaffold for Arteriovenous Fistula Maturation: Unravelling the Role of the Extracellular Matrix;International Journal of Molecular Sciences;2023-06-28